Evidence map›Paper›PMID 40580337›Full record

Trial reportUrolithiasis2025

Intelligent pressure-controlled retrograde intrarenal surgery versus microchannel percutaneous nephrolithotomy to treat 2-3 cm renal calculi.

Zhongsheng Yang, Qiliang Zhai, Junjing Wu, Leming Song, Yongming Huang, Ting Sun

Abstract readRandomized Controlled TrialComparative Study
In one paragraph

Trial report in Urolithiasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhongsheng YangDepartment of Urology, The Affiliated Ganzhou Hospital, Jiangxi Medical College, Nanchang University, Ganzhou, China. zhongshengyang@126.com.
Qiliang ZhaiDepartment of Urology, The Affiliated Ganzhou Hospital, Jiangxi Medical College, Nanchang University, Ganzhou, China.
Junjing WuDepartment of Urology, The Affiliated Ganzhou Hospital, Jiangxi Medical College, Nanchang University, Ganzhou, China.
Leming SongDepartment of Urology, The Affiliated Ganzhou Hospital, Jiangxi Medical College, Nanchang University, Ganzhou, China.
Yongming HuangDepartment of Urology, The Affiliated Ganzhou Hospital, Jiangxi Medical College, Nanchang University, Ganzhou, China.
Ting SunDepartment of Urology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We performed a comparative analysis of intelligent pressure-controlled ureteroscopic lithotripsy (IRIRS) and intelligent pressure-controlled microchannel percutaneous nephrolithotomy (IMPCNL) to treat 2-3 cm renal calculi. Patients (n = 140) with 2-3 cm renal calculi were randomly divided into the IRIRS and IMPCNL groups (n = 70/group). Surgical time, length of hospital stays, stone clearance rate, decrease in hemoglobin level, postoperative pain score, and incidence of complications were compared between groups. The IRIRS group had significantly longer operative durations than the IMPCNL group (average: 58.3 ± 7.4 vs. 52.5 ± 6.8 min). Stone clearance rates at 4 weeks postoperatively were 90.0% and 92.8% in the IRIRS and IMPCNL groups, respectively (P > 0.05). The IRIRS group had shorter hospital stays than the IMPCNL group (1.9 ± 0.3 vs. 3.2 ± 0.4 days). Intraoperative hemoglobin levels decreased more in the IMPCNL (1.03 ± 0.12 g/dL) than in the IRIRS (0.25 ± 0.06 g/dL, P < 0.001) group. Two and one cases in the IRIRS and IMPCNL group, respectively, experienced postoperative fever. The overall complication incidence did not significantly differ (12.9% IRIRS and 15.7% IMPCNL; P > 0.05). IRIRS and IMPCNL are safe, effective interventions for 2-3 cm renal calculi. Given its minimally invasive nature and positive operative safety outcomes, IRIRS has promising future applications.

Indexed as

Kidney CalculiLithotripsyNephrolithotomy, PercutaneousUreteroscopyAdultAgedFemaleHumansLength of StayMaleMiddle AgedOperative TimePostoperative ComplicationsPostoperative PainTreatment OutcomeIntelligent controlled-pressureMicrochannel percutaneous nephrolithotomyRenal calculiRetrograde intrarenal surgery

Identifiers

PMID40580337
PMCPMC12206191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.